Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: Role of PYK2

Cardiovascular Research

Volumn 113, Issue 8, 2017, Pages 926-937

  Bibli, Sofia Iris ^a,b   Zhou, Zongmin ^a   Zukunft, Sven ^b   Fisslthaler, Beate ^b   Andreadou, Ioanna ^a   Szabo, Csaba ^c   Brouckaert, Peter ^d,e   Fleming, Ingrid ^b   Papapetropoulos, Andreas ^a,f  

^a UNIVERSITY OF ATHENS   (Greece)

^b GOETHE UNIVERSITY   (Germany)

^c University of Texas Medical Branch School of Medicine   (United States)

^d GHENT UNIVERSITY   (Belgium)

^e DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^f BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Cardioprotection; Cyclic nucleotide; eNOS; Myocardial infarction; Reperfusion injury

Indexed keywords

CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOCAL ADHESION KINASE 2; HYDROGEN PEROXIDE; SMALL INTERFERING RNA; TYROSINE; NITRIC OXIDE; NOS3 PROTEIN, MOUSE; NOS3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CELL DAMAGE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE SILENCING; HEART INFARCTION SIZE; IMMUNOPRECIPITATION; MALE; MOUSE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; DRUG EFFECT; ENZYME ACTIVATION; HEART INFARCTION; METABOLISM; PHOSPHORYLATION; RAT;

ANIMALS; ENZYME ACTIVATION; FOCAL ADHESION KINASE 2; HYDROGEN PEROXIDE; MALE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; TYROSINE;

EID: 85021823514     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvx058     Document Type: Article

References (53)

1. Yellon DM, Hausenloy DJ.Myocardial reperfusion injury.N Engl J Med 2007;357:1121-1135.
2. Hausenloy DJ, Bøtker HE, Condorelli G, Ferdinandy P, Garcia-Dorado D, Heusch G, Lecour S, van Laake LW, Madonna R, Ruiz-Meana M, Schulz R, Sluijter JPG, Yellon DM, Ovize M.Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Cardiovasc Res 2013;98:7-27.
3. Hausenloy DJ, Yellon DM.Ischaemic conditioning and reperfusion injury.Nat Rev Cardiol 2016;13:193-209.
4. Tang L, Wang H, Ziolo MT.Targeting NOS as a therapeutic approach for heart failure.Pharmacol Ther 2014;142:306-315.
5. Förstermann U, Sessa WC.Nitric oxide synthases: regulation and function.Eur Heart J 2012;33:829-837.
6. Qian J, Fulton D.Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium.Front Physiol 2013;4.
7. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM.Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.Nature 1999;399:601-605.
8. Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC.Regulation of endothelium-derived nitric oxide production by the protein kinase Akt.Nature 1999;399:597-601.
9. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R.Phosphorylation of Thr495 regulates Ca2/calmodulin-dependent endothelial nitric oxide synthase activity.Circ Res 2001;88:e68-e75.
10. Fisslthaler, Dimmeler, Hermann, Busse, Fleming.Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress.Acta Physiol Scand 2000;168:81-88.
11. Fleming I, Bauersachs J, Fisslthaler B, Busse R.Ca2-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress.Circ Res 1998;82:686-695.
12. Fulton D, Church JE, Ruan L, Li C, Sood SG, Kemp BE, Jennings IG, Venema RC.Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83.J Biol Chem 2005;280:35943-35952.
13. Fulton D, Ruan L, Sood SG, Li C, Zhang Q, Venema RC.Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation: role of eNOS phosphorylation at Tyr83.Circ Res 2008;102:497-504.
14. Loot AE, Schreiber JG, Fisslthaler B, Fleming I.Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase.J Exp Med 2009;206:2889-2896.
15. Heusch G.Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.Circ Res 2015;116:674-699.
16. Ferdinandy P, Schulz R.Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.Br J Pharmacol 2003;138:532-543.
17. Jones SP, Bolli R.The ubiquitous role of nitric oxide in cardioprotection.J Mol Cell Cardiol 2006;40:16-23.
18. Sun J, Aponte AM, Kohr MJ, Tong G, Steenbergen C, Murphy E.Essential role of nitric oxide in acute ischemic preconditioning: S-Nitros(yl)ation versus sGC/cGMP/ PKG signaling? Free Rad Biol Med 2013;54:105-112.
19. Garcia-Dorado D, Agullo L, Sartorio CL, Ruiz-Meana M.Myocardial protection against reperfusion injury: the cGMP pathway.Thromb Haemost 2009;101:635-642.
20. Inserte J, Ruiz-Meana M, Rodriguez-Sinovas A, Barba I, Garcia-Dorado D.Contribution of delayed intracellular ph recovery to ischemic postconditioning protection.Antioxid Redox Signal 2010;14:923-939.
21. Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cocheme HM, Reinhold J, Lilley KS, Partridge L, Fearnley IM, Robinson AJ, Hartley RC, Smith RAJ, Krieg T, Brookes PS, Murphy MP.Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.Nat Med 2013;19:753-759.
22. Bayer AL, Heidkamp MC, Patel N, Porter MJ, Engman SJ, Samarel AM.PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy.Am J Physiol Heart Circ Physiol 2002;283:H695-H706.
23. Lang D, Glukhov AV, Efimova T, Efimov IR.Role of Pyk2 in cardiac arrhythmogenesis.Am J Physiol Heart Circ Physiol 2011;301:H975-H983.
24. Fisslthaler B, Loot AE, Mohamed A, Busse R, Fleming I.Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin.Circ Res 2008;102:1520-1528.
25. Michell BJ, Harris MB, Chen Z-P, Ju H, Venema VJ, Blackstone MA, Huang W, Venema RC, Kemp BE.Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635.J Biol Chem 2002;277:42344-42351.
26. Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J.Protein tyrosine kinase PYK2 involved in Ca2-induced regulation of ion channel and MAP kinase functions.Nature 1995;376:737-745.
27. Tokiwa G, Dikic I, Lev S, Schlessinger J.Activation of Pyk2 by stress signals and coupling with JNK signaling pathway.Science 1996;273:792-794.
28. Chappell AE, Bunz M, Smoll E, Dong H, Lytle C, Barrett KE, McCole DF.Hydrogen peroxide inhibits Ca2-dependent chloride secretion across colonic epithelial cells via distinct kinase signaling pathways and ion transport proteins.FASEB J 2008;22:2023-2036.
29. Tai L-K, Okuda M, Abe J-i, Yan C, Berk BC.Fluid shear stress activates proline-rich tyrosine kinase via reactive oxygen species-dependent pathway.Arterioscler Thromb Vasc Biol 2002;22:1790-1796.
30. Takeishi Y.Pivotal roles of regulating the proline-rich tyrosine kinase 2 (PYK2) signaling in cardiac function and remodeling.J Mol Cell Cardiol 2014;74:295-296.
31. Hirotani S, Higuchi Y, Nishida K, Nakayama H, Yamaguchi O, Hikoso S, Takeda T, Kashiwase K, Watanabe T, Asahi M, Taniike M, Tsujimoto I, Matsumura Y, Sasaki T, Hori M, Otsu K.Ca2-sensitive tyrosine kinase Pyk2/CAK b-dependent signaling is essential for G-protein-coupled receptor agonist-induced hypertrophy.J Cell Mol Cardiol 2004;36:799-807.
32. Koshman YE, Chu M, Kim T, Kalmanson O, Farjah M, Kumar M, Lewis W, Geenen DL, de Tombe P, Goldspink PH, Solaro RJ, Samarel AM.Cardiomyocyte-specific expression of CRNK, the C-terminal domain of PYK2, maintains ventricular function and slows ventricular remodeling in a mouse model of dilated cardiomyopathy.J Mol Cell Cardiol 2014;72:281-291.
33. Yang C-M, Lee IT, Hsu R-C, Chi P-L, Hsiao L-D.NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-a-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells.Tox Appl Pharmacol 2013;272:431-442.
34. Matsui A, Okigaki M, Amano K, Adachi Y, Jin D, Takai S, Yamashita T, Kawashima S, Kurihara T, Miyazaki M, Tateishi K, Matsunaga S, Katsume A, Honshou S, Takahashi T, Matoba S, Kusaba T, Tatsumi T, Matsubara H.Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function.Circulation 2007;116:1041-1051.
35. Sartoretto JL, Kalwa H, Shiroto T, Sartoretto SM, Pluth MD, Lippard SJ, Michel T.Role of Ca(2) in the control of H(2)O(2)-modulated phosphorylation pathways leading to eNOS activation in cardiac myocytes.PLoS ONE 2012;7:e44627.
36. Chien PT-Y, Lin C-C, Hsiao L-D, Yang C-M.c-Src/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: role of COX-2 induction.Mol Cell Endocrinol 2015;409:59-72.
37. Melendez J, Welch S, Schaefer E, Moravec CS, Avraham S, Avraham H, Sussman MA.Activation of pyk2/related focal adhesion tyrosine kinase and focal adhesion kinase in cardiac remodeling.J Biol Chem 2002;277:45203-45210.
38. Wei H, Vander Heide RS.Heat stress activates AKT via focal adhesion kinasemediated pathway in neonatal rat ventricular myocytes.Am J Physiol Heart Circ Physiol 2008;295:H561-H568.
39. Chouchani Edward T, Pell Victoria R, James Andrew M, Work Lorraine M, Saeb-Parsy K, Frezza C, Krieg T, Murphy Michael P.A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury.Cell Metabol 2016;23:254-263.
40. Zweier JL, Flaherty JT, Weisfeldt ML.Direct measurement of free radical generation following reperfusion of ischemic myocardium.Proc Natl Acad Sci USA 1987;84: 1404-1407.
41. Inserte J, Hernando V, Vilardosa U, Abad E, Poncelas-Nozal M, Garcia-Dorado D.Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.J Am Heart Assoc 2013;2:e005975.
42. Pong T, Scherrer-Crosbie M, Atochin DN, Bloch KD, Huang PL.Phosphomimetic modulation of eNOS improves myocardial reperfusion and mimics cardiac postconditioning in mice.PLoS ONE 2014;9:e85946.
43. Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G, Zweier JL.Myocardial ischemia results in tetrahydrobiopterin (BH(4)) oxidation with impaired endothelial function ameliorated by BH(4).Proc Natl Acad Sci USA 2007;104:15081-15086.
44. Cai M, Li Y, Xu Y, Swartz HM, Chen C-L, Chen Y-R, He G.Endothelial NOS activity and myocardial oxygen metabolism define the salvageable ischemic time window for ischemic postconditioning.Am J Physiol Heart Circ Physiol 2011;300:H1069-H1077.
45. Calvert JW, Gundewar S, Jha S, Greer JJM, Bestermann WH, Tian R, Lefer DJ.Acute metformin therapy confers cardioprotection against myocardial infarction via AMPKeNOS-mediated signaling.Diabetes 2008;57:696-705.
46. Hamid SA, Totzeck M, Drexhage C, Thompson I, Fowkes RC, Rassaf T, Baxter GF.Nitric oxide/cGMP signalling mediates the cardioprotective action of adrenomedullin in reperfused myocardium.Basic Res Cardiol 2009;105:257-266.
47. Inserte J, Barba I, Poncelas-Nozal M, Hernando V, Agullo L, Ruiz-Meana M, Garcia-Dorado D.cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion.J Mol Cell Cardiol 2011;50:903-909.
48. Giraldez RR, Panda A, Xia Y, Sanders SP, Zweier JL.Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart.J Biol Chem 1997;272:21420-21426.
49. Paolocci N, Biondi R, Bettini M, Lee C-I, Berlowitz CO, Rossi R, Xia Y, Ambrosio G, LAbbate A, Kass DA, Zweier JL.Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart.J Mol Cell Cardiol 2001;33:671-679.
50. Tian Y, Linden J, French BA, Yang Z.Atorvastatin at reperfusion reduces myocardial infarct size in mice by activating eNOS in bone marrow-derived cells.PLoS ONE 2014;9:e114375.
51. Elrod JW, Greer JJM, Bryan NS, Langston W, Szot JF, Gebregzlabher H, Janssens S, Feelisch M, Lefer DJ.Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury.Arterioscler Thromb Vasc Biol 2006;26:1517-1523.
52. Bice JS, Jones BR, Chamberlain GR, Baxter GF.Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies.Bas Res Cardiol 2016;111:23.
53. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R.Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.Pharmacol Rev 2014;66:1142-1174.